Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Similar articles for PubMed (Select 23921569)

1.

Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.

Jeitziner SM, Walton SM, Torti N, Oxenius A.

Eur J Immunol. 2013 Nov;43(11):2886-95. doi: 10.1002/eji.201343690. Epub 2013 Aug 26.

PMID:
23921569
2.

CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain.

Reuter JD, Wilson JH, Idoko KE, van den Pol AN.

J Virol. 2005 Aug;79(15):9527-39.

3.

Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.

Fink A, Lemmermann NA, Gillert-Marien D, Thomas D, Freitag K, Böhm V, Wilhelmi V, Reifenberg K, Reddehase MJ, Holtappels R.

Med Microbiol Immunol. 2012 Nov;201(4):513-25. doi: 10.1007/s00430-012-0256-z. Epub 2012 Sep 9.

PMID:
22961126
4.

T-cell help permits memory CD8(+) T-cell inflation during cytomegalovirus latency.

Walton SM, Torti N, Mandaric S, Oxenius A.

Eur J Immunol. 2011 Aug;41(8):2248-59. doi: 10.1002/eji.201141575. Epub 2011 Jul 4.

PMID:
21590767
5.

Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.

Böhm V, Podlech J, Thomas D, Deegen P, Pahl-Seibert MF, Lemmermann NA, Grzimek NK, Oehrlein-Karpi SA, Reddehase MJ, Holtappels R.

Med Microbiol Immunol. 2008 Jun;197(2):135-44. doi: 10.1007/s00430-008-0092-3. Epub 2008 Mar 14.

PMID:
18340461
6.

Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.

Pavić I, Polić B, Crnković I, Lucin P, Jonjić S, Koszinowski UH.

J Gen Virol. 1993 Oct;74 ( Pt 10):2215-23.

7.

Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.

Zandvliet ML, van Liempt E, Jedema I, Kruithof S, Kester MG, Guchelaar HJ, Falkenburg JH, Meij P.

J Immunother. 2011 Apr;34(3):307-19. doi: 10.1097/CJI.0b013e318213cb90.

PMID:
21389867
8.

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ.

Blood. 2003 Apr 1;101(7):2686-92. Epub 2002 Oct 31.

9.

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.

Reddehase MJ, Mutter W, Münch K, Bühring HJ, Koszinowski UH.

J Virol. 1987 Oct;61(10):3102-8.

10.

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants.

Rauser G, Einsele H, Sinzger C, Wernet D, Kuntz G, Assenmacher M, Campbell JD, Topp MS.

Blood. 2004 May 1;103(9):3565-72. Epub 2003 Dec 11.

11.

Adoptive transfer of murine cytomegalovirus-immune lymph node cells prevents retinitis in T-cell-depleted mice.

Lu Y, Bigger JE, Thomas CA, Atherton SS.

Invest Ophthalmol Vis Sci. 1997 Feb;38(2):301-10.

PMID:
9040462
12.

Thymic humoral factor, THF-gamma 2, enhances immunotherapy of murine cytomegalovirus (MCMV) infection by both CD4+ and CD8+ immune T cells.

Rager-Zisman B, Segev Y, Blagerman S, Palmon A, Tel-Or S, Pecht M, Trainin N, Burstein Y.

Immunol Lett. 1993 Dec;39(1):23-31.

PMID:
7908278
13.

Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.

Quinn M, Turula H, Tandon M, Deslouches B, Moghbeli T, Snyder CM.

J Immunol. 2015 Feb 15;194(4):1726-36. doi: 10.4049/jimmunol.1402757. Epub 2015 Jan 16.

PMID:
25595792
14.

In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.

La Rosa C, Wang Z, Lacey SF, Lalimarmo MM, Krishnan A, Longmate J, Diamond DJ.

Exp Hematol. 2006 Apr;34(4):497-507.

PMID:
16569596
15.

Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.

Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.

J Infect Dis. 2005 Mar 15;191(6):873-80. Epub 2005 Jan 31.

16.

Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.

Holtappels R, Simon CO, Munks MW, Thomas D, Deegen P, Kühnapfel B, Däubner T, Emde SF, Podlech J, Grzimek NK, Oehrlein-Karpi SA, Hill AB, Reddehase MJ.

J Virol. 2008 Jun;82(12):5781-96. doi: 10.1128/JVI.00155-08. Epub 2008 Mar 26.

17.

Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.

Shlobin OA, West EE, Lechtzin N, Miller SM, Borja M, Orens JB, Dropulic LK, McDyer JF.

J Immunol. 2006 Feb 15;176(4):2625-34.

18.

T cell-mediated restriction of intracerebral murine cytomegalovirus infection displays dependence upon perforin but not interferon-gamma.

Cheeran MC, Gekker G, Hu S, Palmquist JM, Lokensgard JR.

J Neurovirol. 2005 Jul;11(3):274-80.

PMID:
16036807
19.

T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.

Popescu I, Pipeling MR, Shah PD, Orens JB, McDyer JF.

J Immunol. 2014 Dec 1;193(11):5709-22. doi: 10.4049/jimmunol.1401436. Epub 2014 Oct 22.

PMID:
25339676
20.

Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.

Sester M, Sester U, Gärtner BC, Girndt M, Meyerhans A, Köhler H.

J Am Soc Nephrol. 2002 Oct;13(10):2577-84.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk